Interesting Clinical Cases in Reproductive-Age Women
Case 1: Recurrent Miscarriage with Underlying Prothrombotic State
A 32-year-old woman with 4 consecutive early pregnancy losses who appears to have normal ovarian function but demonstrates hypercoagulability on thromboelastography (TEG). 1
- This case highlights that recurrent miscarriage may result from underlying prothrombotic states rather than simple hormonal deficiencies 2
- TEG can identify women with significantly higher maximum amplitude (MA ≥ 64 mm) and lower rates of clot lysis, with 68% sensitivity and 82% specificity for predicting subsequent miscarriage 1
- Women with procoagulant defects who receive preconception aspirin and postconception heparin achieve pregnancy success rates exceeding 98% 1
- The diagnostic workup should include antiphospholipid antibodies (lupus anticoagulant and anticardiolipin antibodies), thyroid function tests with TPO antibodies, and consideration of Factor V Leiden and Prothrombin G20210A mutations for second-trimester losses 1, 3
Case 2: PCOS Patient with Dramatically Elevated Miscarriage Risk
A 28-year-old woman with polycystic ovary syndrome (PCOS) diagnosed by ultrasound showing >25 follicles and ovarian volume >10 mL who becomes pregnant and faces an 11-fold increased risk of miscarriage. 4, 5
- Women with pre-pregnancy PCOS have a subsequent miscarriage rate of 33.80% compared to 4.09% in women without PCOS (adjusted OR 11.97; 95% CI 10.27-13.95) 5
- Metformin treatment reduces this risk by approximately 25%, with adjusted OR decreasing from 12.13 to 9.53 5
- PCOS affects at least 7% of adult women and is the leading cause of anovulatory infertility 4
- Ultrasound diagnosis of polycystic ovarian morphology (PCOM) alone is insufficient for PCOS diagnosis, as PCOM appears in up to one-third of reproductive-aged women 4
- Despite the ultrasound findings, 82% of women with PCO and recurrent miscarriage who receive supportive care achieve livebirths 6, 7
Case 3: Young Woman with Pregnancy Loss and Long-Term Cardiovascular Risk
A 29-year-old woman who experiences stillbirth at 36 weeks and faces a 2-fold increased risk of cardiovascular disease-related mortality decades later. 4
- Women with a history of stillbirth have approximately 2-fold increased risk of CVD-related mortality (95% CI 1.90-2.62) compared to women without prior history 4
- Preeclampsia, gestational hypertension, gestational diabetes, placental abruption, and preterm birth all increase subsequent CVD and cerebrovascular morbidity and mortality 4
- The underlying mechanism involves placental and vascular dysfunction with increased inflammation, oxidative stress, and mitochondrial dysfunction 4
- These women require careful short- and long-term cardiovascular follow-up and management 4
- Recurrent pre-eclampsia specifically increases stroke risk more than 2-fold and heart failure risk 4-fold 4
Case 4: Recurrent Miscarriage with Biparental Complete Hydatidiform Mole
A 26-year-old woman with 3 consecutive molar pregnancies who has diploid biparental complete hydatidiform mole (BiCHM) due to familial recurrent hydatidiform mole (FRHM) from NLRP7 gene mutations. 4
- Unlike typical androgenetic complete hydatidiform moles (AnCHM) which are 80% from single sperm duplication and 20% from dispermic fertilization, BiCHM results from autosomal recessive FRHM 4
- Women with FRHM caused by NLRP7 or KHDC3L mutations are unlikely to achieve normal pregnancy except through ovum donation from an unaffected individual 4
- Women with recurrent AnCHM can have normal live births in subsequent pregnancies and benefit from conventional IVF 4
- Genetic testing distinguishes between these conditions and guides appropriate reproductive counseling 4
- All molar pregnancies require careful hCG monitoring for plateaued or rising levels on three and two consecutive samples respectively, indicating malignant change 4
Case 5: High-Risk Pregnancy Requiring Complex Counseling
A 35-year-old woman with WHO class III heart disease who desires pregnancy and requires comprehensive prepregnancy counseling about substantially elevated mortality risk. 4
- Women with WHO class III or IV heart disease face substantially higher mortality risk than those with class I or II disease 4
- Prepregnancy counseling must address risks of adverse pregnancy outcomes, short- and long-term maternal health risks, and fetal/neonatal risks 4
- The first step is assessing the woman's reproductive life plan to determine if she desires pregnancy within the next year 4
- If pregnancy is not desired, contraception counseling should present the most effective options first, consulting the U.S. Medical Eligibility Criteria for Contraceptive Use 4
- Referral to maternal-fetal medicine subspecialists is appropriate for most women at increased risk 4
- Counseling should be nondirective regarding pregnancy continuation versus termination, with expeditious timing to optimize choices 4